MedTrace Logo

Clinical Trials

NCT04821154 | RECRUITING
380 participants

Persona Revision Knee System Outcomes

Study Type:
OBSERVATIONAL
Last Updated:
2026-07-10
Start Date:
2021-06-14
Completion:
2033-12-31
Conditions
  • Arthroplasty Complications
  • Infection
  • Knee Disease
  • Knee Osteoarthritis
Interventions
  • DEVICE
No Results Yet
NCT04712097 | ACTIVE_NOT_RECRUITING | PHASE3
478 participants

A Study Evaluating the Efficacy and Safety of Mosunetuzumab in Combination With Lenalidomide in Comparison to Rituximab in Combination With Lenalidomide With a US Extension of Mosunetuzumab in Combination With Lenalidomide in Participants With Follicular Lymphoma

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-10
Start Date:
2021-10-27
Completion:
2026-06-03
Conditions
  • Relapsed or Refractory Follicular Lymphoma
Interventions
  • DRUG
No Results Yet
NCT04588233 | RECRUITING | NA
80 participants

Melatonin Adolescent Research Study

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-10
Start Date:
2021-09-15
Completion:
2027-05-31
Conditions
  • Sleep Disorders in Children
Interventions
  • DIETARY_SUPPLEMENT
  • OTHER
No Results Yet
NCT04559139 | ACTIVE_NOT_RECRUITING | PHASE2/PHASE3
186 participants

Comparison of Chemotherapy Before and After Surgery Versus After Surgery Alone for the Treatment of Gallbladder Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-10
Start Date:
2021-02-24
Completion:
2028-07-01
Conditions
  • Stage II Gallbladder Cancer AJCC v8
  • Stage IIA Gallbladder Cancer AJCC v8
  • Stage IIB Gallbladder Cancer AJCC v8
  • Stage III Gallbladder Cancer AJCC v8
  • Stage IIIA Gallbladder Cancer AJCC v8
  • Stage IIIB Gallbladder Cancer AJCC v8
Interventions
  • DRUG
  • PROCEDURE
No Results Yet
NCT04482309 | ACTIVE_NOT_RECRUITING | PHASE2
477 participants

A Phase 2 Study of T-DXd in Patients With Selected HER2 Expressing Tumors

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-10
Start Date:
2020-08-18
Completion:
2027-03-23
Conditions
  • Part 1: Bladder, Biliary Tract, Cervical, Endometrial, Ovarian, Pancreatic Cancer, Rare Tumors, Any Tumor Type Excluding Breast, Gastric, Colorectal Cancer
  • Part 2: HER2 Expressing/Amplified Solid Tumors Excluding Breast, Gastric, Colorectal Cancer
Interventions
  • DRUG
No Results Yet
NCT04302051 | WITHDRAWN
0 participants

Assessment of Fatty Liver With Thermo-acoustic Device

Study Type:
OBSERVATIONAL
Last Updated:
2026-07-10
Start Date:
2023-11-02
Completion:
2026-07-09
Conditions
  • NASH
  • NAFLD
  • Non-alcoholic Fatty Liver
  • Non-Alcoholic Fatty Liver Disease
  • Non-alcoholic Steatohepatitis
  • Fatty Liver
  • Fatty Liver Disease
Interventions
  • DIAGNOSTIC_TEST
No Results Yet
NCT04284436 | ACTIVE_NOT_RECRUITING | NA
370 participants

Study in Parkinson Disease of Exercise

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-10
Start Date:
2021-08-30
Completion:
2027-07-31
Conditions
  • Parkinson Disease
Interventions
  • BEHAVIORAL
No Results Yet
NCT04266249 | ACTIVE_NOT_RECRUITING | PHASE2
2175 participants

CompassHER2-pCR: Decreasing Chemotherapy for Breast Cancer Patients After Pre-surgery Chemo and Targeted Therapy

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-10
Start Date:
2020-03-13
Completion:
2027-10-31
Conditions
  • Anatomic Stage II Breast Cancer AJCC v8
  • Anatomic Stage IIA Breast Cancer AJCC v8
  • Anatomic Stage IIB Breast Cancer AJCC v8
  • Anatomic Stage IIIA Breast Cancer AJCC v8
  • Invasive Breast Carcinoma
  • Prognostic Stage II Breast Cancer AJCC v8
  • Prognostic Stage IIA Breast Cancer AJCC v8
  • Prognostic Stage IIB Breast Cancer AJCC v8
  • Prognostic Stage IIIA Breast Cancer AJCC v8
Interventions
  • DRUG
  • PROCEDURE
  • BIOLOGICAL
  • RADIATION
No Results Yet
NCT04248452 | ACTIVE_NOT_RECRUITING | PHASE3
314 participants

Testing the Addition of Radiotherapy to the Usual Treatment (Chemotherapy) for Patients With Esophageal and Gastric Cancer That Has Spread to a Limited Number of Other Places in the Body

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-10
Start Date:
2020-05-26
Completion:
2028-03-31
Conditions
  • Clinical Stage IV Esophageal Adenocarcinoma AJCC v8
  • Clinical Stage IV Gastric Cancer AJCC v8
  • Clinical Stage IVA Esophageal Adenocarcinoma AJCC v8
  • Clinical Stage IVA Gastric Cancer AJCC v8
  • Clinical Stage IVB Esophageal Adenocarcinoma AJCC v8
  • Clinical Stage IVB Gastric Cancer AJCC v8
  • Metastatic Esophageal Adenocarcinoma
  • Metastatic Gastric Adenocarcinoma
  • Oligometastatic Esophageal Adenocarcinoma
  • Oligometastatic Gastric Adenocarcinoma
  • Pathologic Stage IV Esophageal Adenocarcinoma AJCC v8
  • Pathologic Stage IV Gastric Cancer AJCC v8
  • Pathologic Stage IVA Esophageal Adenocarcinoma AJCC v8
  • Pathologic Stage IVB Esophageal Adenocarcinoma AJCC v8
Interventions
  • DRUG
  • RADIATION
No Results Yet
NCT04168372 | ACTIVE_NOT_RECRUITING | NA
35 participants

Fructose: Substrate, Stimulus, or Both?

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-10
Start Date:
2019-09-15
Completion:
2026-12-31
Conditions
  • Insulin Resistance
  • Insulin Sensitivity
  • Pre Diabetes
Interventions
  • OTHER
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page